Navigation Links
Varian Medical Systems Showcases Advanced Radiotherapy Systems for Treating Cancer at 2012 Arab Health Congress and Exhibition
Date:1/23/2012

DUBAI, United Arab Emirates, Jan. 23, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), the world leader in radiotherapy, is spotlighting its family of advanced treatment machines and integrated software solutions at the 2012 Arab Health Congress and Exhibition over the next four days. The Varian exhibit (Sheikh Saeed Hall, Booth No. S3-E40) focuses on latest developments and future innovations in Varian's complete line of medical linear accelerators – including the fast and precise TrueBeam system – along with Eclipse™ treatment planning software, ARIA® oncology information software, proton therapy systems, brachytherapy solutions, and its full range of X-ray tubes and digital image detectors.  

"We are excited to be able to showcase our advanced treatment, software and imaging systems at this prestigious event," says Rolf Staehelin, Varian's director international marketing for EMEA and APAC. "Varian is the clear market leader in radiotherapy and radiosurgery in the Gulf Corporate Council (GCC) countries and is at the forefront of technology advances that help clinicians benefit patients by delivering faster and more efficient treatments. We are looking forward to sharing our excitement about these developments with the radiation oncology community in this key region."

Designed to advance the treatment of lung, breast, prostate, gynaecologic, liver, head and neck, intracranial and other types of cancer, Varian's TrueBeam™ system was engineered from the ground up to treat tumors with unprecedented speed and accuracy. It features a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. With its High Intensity Mode, TrueBeam machines can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of Varian technology.  

During the show, Varian is hosting a symposium on emerging technologies and advanced clinical applications at the American Hospital, Dubai's only radiotherapy center, with presentations followed by a tour of the facility. Key presentations include describing early treatments using Varian's RapidArc® radiosurgery at the American Hospital, as well as using ARIA oncology information software to create a paperless department there. For further information please download the symposium flyer.

As well as radiotherapy systems and software, the Varian booth also showcases the company's range of advanced X-ray tubes and digital image detectors for high quality filmless imaging, developed by the company's X-ray Products group.

Varian and the Middle East
Varian's long-term commitment to the Middle East includes a dedicated customer support services team -- with more than 20 installation, service and applications support personnel – as well as a regional sales office in Riyadh, a bonded warehouse facility in Bahrain and a spare parts bank in Saudi Arabia. The first clinical TrueBeam system in the Middle East is operating at the Azizia Royal Clinic in Riyadh, Saudi Arabia.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

     


'/>"/>
SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 9, 2016 On Tuesday, February ... met with its Arthritis Advisory Committee to ... Johnson & Johnson,s Remicade and most likely ... the U.S. The Biologics Prescribers Collaborative (BPC) ... Alliance for Patient Access, American Association of ...
(Date:2/10/2016)... February 10, 2016 The campaign aims ... 5 years reach the milestone of their 5 th ... ensure 2,50,532 children between the ages of 2 - 5 ... --> The campaign aims to ... reach the milestone of their 5 th birthday   ...
(Date:2/9/2016)... FARMINGDALE, N.Y., Feb. 9, 2016  Misonix, Inc. ... company that designs, manufactures and markets innovative therapeutic ... wound debridement, cosmetic surgery, laparoscopic surgery and other ... second quarter and the first half of fiscal ... --> --> Highlights ...
Breaking Medicine Technology:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Ongoing news ... Aging Life Care Association™ (ALCA) to conduct a survey that takes a closer look ... released today illustrates the prevalence and causes of TBI among the aging population, and ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading ... the fourth quarter and full year ended December 31, 2015 on Monday, February 29, ... webcast for the investment community following the release at 4:30 PM ET. Investors interested ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association ... inspirational speaker Jan Fox will serve as keynote speaker at the organization’s 2016 ... with tools to more effectively communicate with their own organizational staff and leadership. ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , ... with Age: The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp ... publication date is March 16, 2016. A free review copy is available to ...
Breaking Medicine News(10 mins):